Needham & Company LLC Forecasts Strong Price Appreciation for DENTSPLY SIRONA (NASDAQ:XRAY) Stock

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price upped by investment analysts at Needham & Company LLC from $23.00 to $25.00 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s target price points to a potential upside of 26.52% from the stock’s current price.

A number of other brokerages have also issued reports on XRAY. Evercore ISI restated an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Robert W. Baird lowered their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price target for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Finally, UBS Group reduced their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Ten research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and an average target price of $26.33.

DENTSPLY SIRONA Trading Down 2.7 %

NASDAQ XRAY opened at $19.76 on Thursday. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $35.36. The company has a market capitalization of $3.93 billion, a price-to-earnings ratio of -9.55, a price-to-earnings-growth ratio of 1.87 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm’s fifty day moving average price is $19.15 and its 200 day moving average price is $22.50.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business’s revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.49 earnings per share. On average, sell-side analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors have recently added to or reduced their stakes in the stock. UMB Bank n.a. increased its position in shares of DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after buying an additional 753 shares in the last quarter. Capital Performance Advisors LLP acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at about $27,000. MassMutual Private Wealth & Trust FSB increased its holdings in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,232 shares in the last quarter. Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA during the third quarter worth about $35,000. Finally, Van ECK Associates Corp purchased a new stake in shares of DENTSPLY SIRONA in the third quarter valued at about $42,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.